Alfred Reszka, Merck & Co.
Alfred Reszka, Executive Director and Head, Strategic Business Intelligence, Merck & Co.
Alfred “Al” Reszka is Executive Director and Head, Strategic Business Intelligence at Merck. He and his team include clients from R&D to marketing and manufacturing across a variety of business functions requiring scientific, medical and business intelligence. Roles and responsibilities include strategic benchmarking and strategy development, product surveillance, biosimilars, Diversified Brands, emerging markets, Osteoporosis and women’s health licensing, business development, and M&A.
Prior to joining the Global Competitive Intelligence group in 2007, Dr. Reszka was Senior Research Fellow in Bone Basic Research at Merck, where he conducted research into the mechanism of action of FOSAMAX and lead the drug discovery effort. He joined Merck in 1997 after conducting postdoctoral research on molecular signal transduction with Nobel Laureates, Edmund Fischer and Edwin Krebs at the University of Washington in Seattle. Dr. Reszka earned his PhD in 1992 at the University of Illinois, Champaign-Urbana.
Marjorie Norman, Pfizer
Marjorie Norman, Director, Worldwide Competitive Intelligence, Pfizer
Marjorie G. Norman is Director, Worldwide Competitive Intelligence for Pfizer, specializing in providing business and competitive intelligence to senior R&D management. Prior to joining Pfizer in 2002, she was Director – Pharmaceutical Practice, at Fuld & Company, a competitive intelligence consulting firm and a Senior Market Research Analyst at Johnson & Johnson Professional. Ms. Norman holds an MBA from the Graduate School of Management at Simmons College and a BA in German and art history from Franklin & Marshall College. She recently returned from a six-month deployment at Population Services International in Nairobi, Kenya, as part of the Pfizer Global Health Fellows program.